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Abstract
Background : Number and function of Endothelial Progenitor Cells (EPC) are reduced in coronary artery disease (CAD) patient. 
EPC as progenitor of mature endothelial cell has important role for angiogenesis and neovasculogenesis. Dysfunctional EPC partly 
because of oxidative stress. Decreasing oxidative stress with antioxidant especially with sweet purple potato extract and vitamin 
as easily found in Indonesia, may improve EPC migration to ischemic organ in stable CAD patient. To analyze effect of sweet 
purple potato (Ipomoea batatas L.) extract and vitamin C on Endhotelial Progenitor Cell in Stable Coronary Disease patient.
Methods : This is experimental post-test control group study. Mononuclear cells (MNC) are isolated from peripheral blood 
of sample, and cultivated in medium for 3 days, immunofluorescence assay with CD34 as a marker for EPC. EPCs divided into 
sweet purple potato extract group (1 and 25 mcg/mL), vitamin C group (10 and 250 mcg/mL) and control, incubated for 2 days. 
5x105 cell taken from each group and place in upper chamber of Transwell system. EPC migration was assessed in lower cham-
ber of Transwell system after 24 hours using automated cell counters. Statistic testing using ANOVA.
Results : EPC migration was increased significantly in sweet purple potato extract and vitamin C compared with control (3.03 ± 
0.01, 2.15 ± 0.03 vs control 1.21 ± 0.04, p<0.01). Increased dose of sweet purple potato extract and vitamin C shows signifi-
cantly increased of EPC migration (1.81 ± 0.02 vs 3.03 ± 0.01 and 1.47 ± 0.04 vs 2.15 ± 0.03, p<0.01). There is significantly 
differentiation between sweet potato purple extract and vitamin C (3.03 ± 0.01 vs 2.15 ± 0.03, p<0.01).
Conclusion : Sweet purple potato extract and vitamin C increased EPC migration dose-dependently. Sweet purple potato ex-
tract induces EPC migration better than vitamin C.
(Indonesian J Cardiol. 2019;40:326-331)
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Introduction 
Cardiovascular disease (CVD) is one of the biggest cause of deaths worldwide. About 17.7 millions people die because of CVD, 7.4 millions from it because of coronary 
artery disease (CAD).1 Pathophysiology of CAD is 
atherosclerosis. Atherosclerotic lesions are initiated 
from endothelial dysfunction, vascular inflammatory, 
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oxidative stress, platelet aggregation and smooth muscle 
proliferation which develop CAD.2 Stable coronary 
artery disease is generally characterized by a disease 
causing exercise- and stress-related chest symptoms 
due to narrowing of ≥50% in the left main coronary 
artery and ≥70% in one or several of the major coronary 
arteries.3 Study of endothelial progenitor cell (EPC) by 
Asahara et al, shows that endothelium has the ability 
to repair itself and diferentiated into mature cells.4 
Decreasing of EPC shown in stable CAD patients. 
Some of the mechanisms that can cause this include 
increased apoptosis of premature progenitor cells, 
increased oxidative stress that can cause cell death, 
and also interfere with signal pathways that regulate 
differentiation or migration EPC.5 Experimental and 
clinical studies have shown there are various ways to 
increase circulating EPCs and improve their function. 
Cardiovascular pharmacotherapies have been shown 
to improve overall numbers and function of EPCs, 
such as statins, angiotensin converting enzyme (ACE) 
inhibitors, calcium channel blockers (CCBs). Neutricals 
as a endogen antioxidant and antiinflamation, such as 
flavonoid, curcumin, vitamin C and E work to protect 
edhothelial and inhibit atherosclerosis.6 
 Giving antioxidants is expected to improve EPC 
function such as migration. Anthocyanin in purple 
sweet potato (Ipomoea batatas L.) has antioxidant 
function as well as vitamin C. Administration of 
anthocyanin in endothelial cells in vitro can inhibit the 
production of proinflammatory interleukins.7 Ascorbic 
acid in vitamin C works to prevent low density protein 
(LDL) oxidation and inhibits endothelial and leukocyte 
cell interactions induced by cigarette smoke or oxidized 
LDL.8 Antioxidants derived from purple sweet potato 
and vitamin C have been studied to have an effect on 
increasing EPC proliferation, but their role in EPC 
migration is unknown, so that further research is 
needed.9
Methods
Blood samples were taken from patients with stable 
CAD which were men, 40-59 years old, had narrowing 
of ≥50% in the left main coronary artery and ≥70% 
in one or several of the major coronary arteries from 
angiography. Patients with history of acute myocardial 
infarction, acute limb ischemia, stent placement, 
coronary artery bypass grafting, diabetes mellitus, 
smoking, and anemia were excluded. Written informed 
consent was obtained from patients before peripheral 
blood sampling. The protocol was approved by local 
ethics committee.
Isolated and Culture of EPC
40 ml of blood was diluted with phosphate buffered 
saline (PBS) containing 2% of fetal bovine serum 
(FBS). It was then centrifuged on Ficoll-Histopaque 
density gradients and interface mononuclear cells 
(MNCs) were collected. After two washes in PBS 
con- taining 2% of FBS, the pellet were diluted 
with Stemline II Hematopoietic Stemcell Expansion 
Medium plus VEGF, and these cells were counted using 
hemocytometry. MNC with cell density 5x105 cells/ml 
were plated on fibronectin coated 6-well plates. After 
three days, nonadherent cells were transferred into new 
well. Take some cell for immunofluorescence assay.
Immunofuorescence Assay 
Cells were washed with PBS and xed with 3% 
formaldehyde for 15 minutes. Cells then added with 
1% serum and washed again with PBS. Cells were 
stained with a FITC anti-CD34 antibody. Expression of 
the cells was documented with fluorescence microscope.
Purple Sweet Potato (Ipomoea batatas L.) Ex-
tract and Vitamin C
After three day of cultured, EPCs divided into sweet 
purple potato extract group (1 and 25 mcg/mL), vitamin 
C group (10 and 250 mcg/mL) and control, incubated 
for 2 days.
Migration Assay
5x105 cell taken from each group and place in upper 
chamber of Transwell system. EPC migration was 
assessed in lower chamber of Transwell system after 24 
hours using automated cell counters.
Statistical Analysis
Data are expressed asmean±SD. To analyse differences, 
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one-way ANOVA was used. Differences were considered 
significant if p-values were <0.01. All statistical analyses 
were performed with SPSS for Windows.
Results
Immunofuorescence Assay 
CD34 is one of the positive marker of EPC. Expression 
of CD34 was green under fluorescence microscope 
(Figure 1).
Figure 1. Immunofluorescence expression of CD34 marker
Purple Sweet Potato (Ipomoea batatas L.) Ex-
tract increase EPC Migration
To investigate the effect of purple sweet potato (Ipomoea 
batatas L.) extract on EPC migration, we added two 
different dose of each group on EPC cultures. EPC 
migration was increased significantly in low dose (1 
mcg/mL) and high dose (25 mcg/mL) sweet purple 
potato extract compared with control (3.03 ± 0.01, 
1.81 ± 0.02 vs control 1.21 ± 0.04, p<0.01). Increased 
dose of sweet purple potato extract shown significantly 
increased of EPC migration (3.03 ± 0.01 vs 1.81 ± 0.02, 
p<0.01) (Figure 2).
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Figure 2. EPC migration with purple sweet potato extract 
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Figure 2. EPC migration with purple sweet potato extract
Vitamin C increase EPC Migration
EPC migration was increased significantly in low 
dose (10 mcg/mL) and high dose (250 mcg/mL) 
vitamin C compared with control (2.15 ± 0.03, 1.47 
± 0.04 vs control 1.21 ± 0.04, p<0.01). Vitamin C 
shows significantly increased of EPC migration dose 
dependently (2.15 ± 0.03 vs 1.47 ± 0.04, p<0.01). 
(Figure 3).
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Figure 4. Comparison chart of EPC migration between groups of purple sweet potato 
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Figure 3. EPC migration with vitamin C
Comparation Purple Sweet Potato (Ipomoea 
batatas L.) Extract with Vitamin C in EPC 
Migration
EPC migration in low dose (1 mcg/mL) of purple sweet 
potato (Ipomoea batatas L.) extract shown increased 
significantly compare to low dose (10 mcg/mL) of 
vitamin C (1.81 ± 0.02 vs 1.47 ± 0.04, p<0.01). Thus 
high dose (25 mcg/mL) of purple sweet potato (Ipomoea 
batatas L.) extract shown increased significantly 
compare to high dose (250 mcg/mL) of vitamin C (3.03 
± 0.01 vs 2.15 ± 0.03, p<0.01). (Table 1). These result 
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Table 1. Comparison chart of EPC migration between groups of purple sweet potato extract with vitamin C in 
low and high doses.
Purple sweet potato group
(Mean±SD)
Vitamin C group
(Mean±SD) p-value
1 mcg/mL (1.81 ± 0.02)
25 mcg/mL (3.03 ± 0.01)
10 mcg/mL (1.47 ± 0.04)
250 mcg/mL (2.15 ± 0.03)
0.000
0.000
demonstrate that purple sweet potato extract increased 
EPC migration better than vitamin C (Figure 4).
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Discussions
 The result of these study demonstrate that purple 
sweet potato extract increase EPC migration in 
peripheral bood of stable CAD patient. Increase of EPC 
migration by purple sweet potato (Ipomoea batatas L.) 
extract is dose-dependent, the higher dose of purple 
sweet potato extract increase EPC migration. This result 
equal with previous study by Suastika et al, shows that 
purple sweet potato extract increase EPC proliferation. 
9 Addition of purple sweet potato extract which works 
as an exogenous antioxidant is useful in EPC protection 
against oxidative stress. The anthocyanin inside purple 
sweet potato is quite high compared to other foods, can 
help in reducing oxidative stress. 10 In studies using 
anthocyanin containing chockberry extract which also 
originates from the flavanoid group, it was found that the 
migration process toward ischemic tissue was increased. 
The mechanism underlying this is still uncertain, 
from a study by Deshane et al in 2007 and Parzonko 
et al in 2015, a mechanism thought to originate from 
the activation of the Pl3K / Akt pathway by SDF-
1 which would affect the PKC and MAPK pathways 
and would activate HO- 1 resulting in an increase in 
EPC migration. This pathway can also underlie the 
occurrence of EPC migration to tissue that ischemia in 
the process of atherosclerosis. 11,12
 EPC migration was increase in the addition of 
vitamin C peripheral bood of stable CAD patient. 
This increase EPC migration in administration of 
vitamin C is also dose-dependent. Suastika et al 
stated that administration of vitamin C also increases 
EPC proliferation dose dependently. This shows that 
admition of vitamin C increases number of EPC and 
repair EPC function in CAD patients. 9 Vitamin C as an 
antioxidant works to inhibit LDL oxidation and improve 
eNOS bonds which will increase the bioavailability of 
NO. NO formation will protect vascular endothelium. 
NO plays a role in relaxation of smooth muscle cells, 
peripheral vasodilation and prevents the effects of 
proinflammatory cytokines and adhesion molecules in 
the process of atherosclerosis. This also underlies the 
beneficial effects of vitamin C on EPC migration.13,14,15
 In this study the administration of low dose (1 mcg/
mL) purple sweet potato extract gave a higher migration 
effect compare to low dose (10 mcg/mL) vitamin C. 
Likewise with the administration of high doses (25 
mcg/mL) purple sweet potato extract increased EPC 
migration significantly compared with high dose (250 
mcg/mL) vitamin C. This shows the administration 
of sweet potato extract purple is better in the EPC 
migration compared to vitamin C. The differences in the 
mechanism of action and the antioxidant transduction 
pathway of these two groups are also thought to have 
an effect on EPC migration. Anthocyanin purple sweet 
potato extract is thought to work through the Pl3K / 
Akt pathway which will activate HO-1 while vitamin C 
works as an electron donor to capture ROS which will 
activate eNOS to NO.11,12,13,14,15
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Figure 5. EPC that has migrated to the Transwell lower chamber: A. Group of purple 
sweet potato extract 1 mcg/mL; B. Group of purple sweet potato extract 25 mcg/mL; 
C. Group of vitamin C 10 mcg/mL; Group of vitamin C 250 mcg/mL; D. Controls 
group 
 
Table 1. Comparison chart of EPC migration between groups of purple sweet potato 
extract with vitamin C in low and high doses. 
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(Mean±SD) 
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(Mean±SD) 
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Figure 5. EPC that has migrated to the Transwell lower 
chamber: A. Group of purple sweet potato extract 1 cg/
mL; B. Group of purple sweet tato extract 25 cg/mL; C. 
Group of vitamin C 10 mcg/mL; Group of vitamin C 250 
mcg/mL; D. Controls group
Conclusion
The result of the present study define that purple 
sweet potato (Ipomoea batatas L.) extract increased 
EPC migration dose-dependently. Sweet purple potato 
(Ipomoea batatas L.) extract induces EPC migration 
better than vitamin C in stable CAD patient.
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List of Abbreviations
ACE: angiotensin converting enzyme
CAD: coronary artery disease
CCB: calcium channel blocker 
CVD: cardiovascular disease
eNOS: endothelial nitric oxide synthase
EPC: endothelial progenitor cell
FBS: phosphate buffered saline
HO-1: heme oxygenase-1
LDL: low density protein
MAPK: mitogen activated protein kinase
MNC: mononuclear cell
NO: nitric oxide
PBS: phosphate buffered saline
P13K: phosphatidylinositol-3 kinase
SD: standart deviation
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